These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15266220)

  • 1. Some plasma and saliva pharmacokinetics parameters of rifampicin in the presence of pefloxacin.
    Orisakwe OE; Akunyili DN; Agbasi PU; Ezejiofor NA
    Am J Ther; 2004; 11(4):283-7. PubMed ID: 15266220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pefloxacin on the urinary excretion of rifampicin.
    Orisakwe OE; Agbasi PU; Ofoefule SI; Ilondu NA; Afonne OJ; Anusiem CA; Ilo CE; Maduka SO
    Am J Ther; 2004; 11(1):13-6. PubMed ID: 14704591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin pharmacokinetics with and without ciprofloxacin.
    Orisakwe OE; Agbasi PU; Afonne OJ; Ofoefule SI; Obi E; Orish CN
    Am J Ther; 2001; 8(3):151-3. PubMed ID: 11344382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.
    Conte JE; Golden JA; Kipps JE; Lin ET; Zurlinden E
    Clin Pharmacokinet; 2004; 43(6):395-404. PubMed ID: 15086276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers.
    Medellín-Garibay SE; Milán-Segovia Rdel C; Magaña-Aquino M; Portales-Pérez DP; Romano-Moreno S
    J Pharm Pharmacol; 2014 Oct; 66(10):1421-8. PubMed ID: 24841364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and saliva concentrations of rifampicin in man after oral administration.
    Orisakwe OE; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):45-9. PubMed ID: 9239804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pefloxacin on urinary and salivary concentrations of isoniazid in six healthy female volunteers.
    Ofoefule SI; Onyeagba OE; Orisakwe OE
    Am J Ther; 2000 Sep; 7(5):313-6. PubMed ID: 11317177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of rifampin on the pharmacokinetics of pefloxacin.
    Humbert G; Brumpt I; Montay G; Le Liboux A; Frydman A; Borsa-Lebas F; Moore N
    Clin Pharmacol Ther; 1991 Dec; 50(6):682-7. PubMed ID: 1752112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market.
    Pillai G; Fourie PB; Padayatchi N; Onyebujoh PC; McIlleron H; Smith PJ; Gabriels G
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S309-16; discussion S317-21. PubMed ID: 10593710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations.
    Pillai G; Ellard GA; Smith PJ; Fourie PB
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):691-5. PubMed ID: 11495257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.
    López-Cortés LF; Ruiz-Valderas R; Viciana P; Alarcón-González A; Gómez-Mateos J; León-Jimenez E; Sarasanacenta M; López-Pua Y; Pachón J
    Clin Pharmacokinet; 2002; 41(9):681-90. PubMed ID: 12126459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pooling methodology as a faster and cheaper tool to evaluate bioequivalence of rifampicin component of FDCs of antitubercular drugs.
    Panchagnula R; Sharma A; Agrawal S
    Pharmacol Res; 2003 Dec; 48(6):655-63. PubMed ID: 14527833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of a new 3-azinomethyl rifamycin (SPA-S-565) in volunteers as compared with conventional rifampicin.
    Kelkar MS; Saraf AP; Bakhle DS; Nazare V; Ajay S; Hegde S; Lal HM; Cooverji ND; Bruzzese T
    Int J Clin Pharmacol Res; 1998; 18(3):137-43. PubMed ID: 9825270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):474-81. PubMed ID: 12395981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Food on Rifampicin Pharmacokinetics in Rats.
    Shimomura H; Nogami R; Shigeno A; Shimada S; Aoyama T
    Biol Pharm Bull; 2016; 39(1):49-53. PubMed ID: 26725427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ofloxacin and norfloxacin on rifampicin pharmacokinetics in man.
    Ezejiofor NA; Brown S; Barikpoar E; Orisakwe OE
    Am J Ther; 2015; 22(1):29-36. PubMed ID: 23817346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration.
    Malik JK; Rao GS; Ramesh S; Muruganandan S; Tripathi HC; Shukla DC
    Vet Res Commun; 2002 Feb; 26(2):141-9. PubMed ID: 11922483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin reduces plasma concentrations of celiprolol.
    Lilja JJ; Niemi M; Neuvonen PJ
    Eur J Clin Pharmacol; 2004 Jan; 59(11):819-24. PubMed ID: 14614579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of rifampicin in the presence of ciprofloxacin.
    Orisakwe OE; Afonne OJ; Agbasi PU; Ofoefule SI
    Am J Ther; 2004; 11(3):171-4. PubMed ID: 15133531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.